Skip to main content
. 2020 Aug 2;130:104572. doi: 10.1016/j.jcv.2020.104572

Table 2.

Assay specificity calculated for each SARS-CoV-2 antigen from the control cohort.

Antigen n Positive Negative Specificity (95 % CI) (%)
CoV-2 S 194 5 189 97.4 % (94.1 to 98.9)
CoV-2 RBD 194 15 179 92.3% (87.6 to 95.3)
CoV-2 N 194 14 180 92.8 % (88.2 to 95.7)